Welcome to our dedicated page for Scworx SEC filings (Ticker: WORX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Wondering where to find the next clue about SCWorx’s hospital-data SaaS growth? Every answer hides inside the company’s SEC disclosures—from its sprawling annual report to a single Form 4 insider sale. Stock Titan’s AI engine turns those dense documents into plain-English insights, so you can move from reading to decision-making in minutes.
Start with the SCWorx annual report 10-K simplified: our summaries highlight subscription revenue trends, R&D spend on data-interoperability modules, and any HIPAA compliance risks. Need fresh numbers? The SCWorx quarterly earnings report 10-Q filing is parsed instantly, letting you track hospital-contract renewals without digging through footnotes. Sudden developments arrive via SCWorx 8-K material events explained, while the proxy reveals executive pay structures in the SCWorx proxy statement executive compensation.
- SCWorx insider trading Form 4 transactions delivered in real time—monitor buying or selling before it moves the tape.
- SCWorx Form 4 insider transactions real-time alerts directly to your dashboard or inbox.
- AI-driven “what-it-means� notes for every footnote�understanding SCWorx SEC documents with AI has never been easier.
Whether you’re running an earnings-model or screening micro-cap healthcare IT names, our platform answers the questions investors actually ask: “How do I read SCWorx’s 10-K?� “Is there a new financing 8-K?� “Where are SCWorx executive stock transactions Form 4 listed?� With comprehensive coverage, real-time updates from EDGAR, and AI that spots the metrics that matter, SCWorx SEC filings explained simply becomes more than a promise—it’s your new workflow.
SCWorx Corp. reported a six-month decline in revenue to $1,402,931 from $1,554,126 a year earlier and a widened net loss of $2,382,388 versus $515,972, driven largely by significant non-cash interest and debt discount amortization related to new convertible financings.
The balance sheet shows $340,209 in cash, $412,216 of net accounts receivable and total assets of $6,645,933. Accumulated deficit totaled $33,358,454 and deferred revenue was $219,250. During the period the company issued aggregate convertible notes of $2,655,000 and recognized substantial amortization of debt discounts ($1,458,243 for six months), and it issued warrants totaling 43,907,807 shares, creating potential dilution. Management discloses substantial doubt about the company’s ability to continue as a going concern within one year and a Nasdaq minimum bid-price deficiency, with a compliance window available.
SCWorx Corp. Schedule 13G/A discloses that Iroquois Capital Management, LLC, Richard Abbe and Kimberly Page report beneficial interests in the issuer through outstanding warrants and convertible notes. The filing shows reported aggregates of 403,850 shares for Richard Abbe (reported as 9.99% of the class) and 305,524 shares for each of Iroquois Capital and Kimberly Page (reported as 7.75% of the class). These reported amounts include shares issuable upon conversion/exercise but are limited by contractual Beneficial Ownership Blockers that restrict conversion/exercise to 4.99% or 9.99% thresholds, so all instruments could not be converted or exercised as reported. Some Convertible Notes convert at a stated conversion price of $0.3496. The reporting persons disclaim beneficial ownership except to the extent of their pecuniary interest and certify the securities were not acquired to change or influence control of the issuer.
FAQ
What is the current stock price of Scworx (WORX)?
What is the market cap of Scworx (WORX)?
